Proactive Investors
24 Jun 2026, 07:05 UTC · 2h ago
ImmuPharma flags Murcia research into P140 as potential brain cancer treatment
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Proactive Investors
24 Jun 2026, 07:05 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Empire Metals Ltd reported multiple thick, near-surface intercepts above 7% TiO₂ at the Pitfield titanium project. — High-grade drilling results in a 'defining' campaign typically trigger positive price movement for junior mining stocks.
+0.60ImmuPharma PLC highlighted new research from the University of Murcia suggesting its lead drug candidate, P140, may treat glioblastoma brain cancer. — Expanding the potential therapeutic application of a lead asset increases the addressable market and value proposition of a biotech firm.
+0.40ImmuPharma PLC stated that its primary strategic focus remains treating autoimmune diseases rather than cancer. — This clarifies that the cancer research is secondary, potentially tempering expectations for a pivot to a high-value oncology market.
-0.10Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company delivered strong early results from its largest drilling campaign, confirming a high-grade core.
The company highlighted new research supporting its lead drug candidate's potential to treat aggressive brain cancer.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
4h ago
